US inks deal with Moderna for 100 million doses of COVID vaccine: Trump
Washington: The United States has made an agreement with the pharmaceutical company Moderna to deliver 100 million doses of their novel coronavirus vaccine once it becomes available, said President Donald Trump on Tuesday.
"This evening, I am pleased to announce that we have reached an agreement with Moderna to manufacture and deliver one hundred million doses of their coronavirus vaccine candidate," Trump said on Tuesday evening while addressing reporters.
Moderna said that the US government awarded the company USD 1.5 billion for 100 million doses of its vaccine once it is ready. The vaccine is currently undergoing the phase of a clinical trial, which began on July 27.
The company also said the US government will have the option to purchase an additional 400 million doses of the vaccine if needed.
Read also: Pfizer, Moderna Strike Deals With Canada For Supply Of COVID-19 Vaccines
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.